Globus Historical Financial Ratios

GMED Stock  USD 81.78  1.64  1.97%   
Globus Medical is recently reporting on over 108 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 1.43 or Days Sales Outstanding of 123 will help investors to properly organize and evaluate Globus Medical financial condition quickly.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.

About Globus Financial Ratios Analysis

Globus MedicalFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Globus Medical investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Globus financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Globus Medical history.

Globus Medical Financial Ratios Chart

At present, Globus Medical's Days Sales Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 37.12, whereas Operating Cash Flow Per Share is forecasted to decline to 1.18.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Globus Medical stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Globus Medical sales, a figure that is much harder to manipulate than other Globus Medical multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.
Most ratios from Globus Medical's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Globus Medical current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.At present, Globus Medical's Days Sales Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 37.12, whereas Operating Cash Flow Per Share is forecasted to decline to 1.18.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding63.1177.55117.49123.36
PTB Ratio4.184.041.511.43

Globus Medical fundamentals Correlations

0.620.00.14-0.640.62-0.080.620.980.52-0.43-0.430.670.10.270.290.650.720.33-0.010.14-0.220.25-0.410.810.76
0.62-0.7-0.64-0.470.020.531.00.53-0.020.390.190.23-0.650.130.340.030.52-0.150.20.3-0.06-0.150.410.360.22
0.0-0.70.95-0.180.27-0.67-0.70.070.2-0.78-0.480.130.93-0.06-0.090.350.120.40.010.02-0.030.19-0.770.230.31
0.14-0.640.95-0.160.48-0.75-0.640.230.43-0.88-0.610.260.970.14-0.190.530.140.59-0.14-0.09-0.220.36-0.880.340.47
-0.64-0.47-0.18-0.16-0.05-0.19-0.47-0.540.10.170.36-0.29-0.180.04-0.43-0.26-0.94-0.2-0.63-0.71-0.040.240.14-0.64-0.5
0.620.020.270.48-0.05-0.510.020.710.97-0.71-0.640.680.360.49-0.20.90.140.62-0.54-0.4-0.460.77-0.70.530.74
-0.080.53-0.67-0.75-0.19-0.510.53-0.18-0.560.770.46-0.13-0.71-0.190.62-0.490.08-0.550.540.380.17-0.560.79-0.25-0.44
0.621.0-0.7-0.64-0.470.020.530.53-0.020.390.190.23-0.650.130.340.030.52-0.150.20.3-0.06-0.150.410.360.22
0.980.530.070.23-0.540.71-0.180.530.61-0.54-0.480.740.170.270.170.740.630.37-0.18-0.04-0.210.34-0.530.860.78
0.52-0.020.20.430.10.97-0.56-0.020.61-0.66-0.530.570.30.5-0.320.82-0.010.61-0.65-0.48-0.460.82-0.660.390.66
-0.430.39-0.78-0.880.17-0.710.770.39-0.54-0.660.64-0.42-0.81-0.20.22-0.75-0.17-0.510.390.290.22-0.591.0-0.55-0.69
-0.430.19-0.48-0.610.36-0.640.460.19-0.48-0.530.64-0.54-0.66-0.320.19-0.73-0.47-0.590.080.010.32-0.430.63-0.64-0.7
0.670.230.130.26-0.290.68-0.130.230.740.57-0.42-0.540.210.00.070.680.430.49-0.24-0.210.00.11-0.40.750.39
0.1-0.650.930.97-0.180.36-0.71-0.650.170.3-0.81-0.660.210.12-0.160.420.190.54-0.04-0.01-0.190.25-0.810.340.42
0.270.13-0.060.140.040.49-0.190.130.270.5-0.2-0.320.00.12-0.110.370.030.33-0.2-0.1-0.970.67-0.210.090.58
0.290.34-0.09-0.19-0.43-0.20.620.340.17-0.320.220.190.07-0.16-0.11-0.230.33-0.380.680.570.02-0.410.25-0.03-0.08
0.650.030.350.53-0.260.9-0.490.030.740.82-0.75-0.730.680.420.37-0.230.350.63-0.41-0.3-0.330.69-0.750.710.83
0.720.520.120.14-0.940.140.080.520.63-0.01-0.17-0.470.430.190.030.330.350.310.530.65-0.02-0.2-0.150.750.56
0.33-0.150.40.59-0.20.62-0.55-0.150.370.61-0.51-0.590.490.540.33-0.380.630.31-0.19-0.02-0.360.33-0.520.440.48
-0.010.20.01-0.14-0.63-0.540.540.2-0.18-0.650.390.08-0.24-0.04-0.20.68-0.410.53-0.190.950.12-0.630.42-0.09-0.15
0.140.30.02-0.09-0.71-0.40.380.3-0.04-0.480.290.01-0.21-0.01-0.10.57-0.30.65-0.020.950.04-0.50.320.00.03
-0.22-0.06-0.03-0.22-0.04-0.460.17-0.06-0.21-0.460.220.320.0-0.19-0.970.02-0.33-0.02-0.360.120.04-0.620.23-0.05-0.52
0.25-0.150.190.360.240.77-0.56-0.150.340.82-0.59-0.430.110.250.67-0.410.69-0.20.33-0.63-0.5-0.62-0.60.140.67
-0.410.41-0.77-0.880.14-0.70.790.41-0.53-0.661.00.63-0.4-0.81-0.210.25-0.75-0.15-0.520.420.320.23-0.6-0.53-0.68
0.810.360.230.34-0.640.53-0.250.360.860.39-0.55-0.640.750.340.09-0.030.710.750.44-0.090.0-0.050.14-0.530.7
0.760.220.310.47-0.50.74-0.440.220.780.66-0.69-0.70.390.420.58-0.080.830.560.48-0.150.03-0.520.67-0.680.7
Click cells to compare fundamentals

Globus Medical Account Relationship Matchups

Globus Medical fundamentals Accounts

201920202021202220232024 (projected)
Price To Sales Ratio7.438.157.597.33.844.16
Ptb Ratio4.164.274.184.041.511.43
Days Sales Outstanding75.4968.5163.1177.55117.49123.36
Book Value Per Share14.1415.2817.2918.3835.3537.12
Free Cash Flow Yield0.02880.01730.0210.03020.0140.0355
Operating Cash Flow Per Share1.732.022.741.782.151.18
Stock Based Compensation To Revenue0.03320.03430.03190.03210.03360.0178
Capex To Depreciation1.341.010.811.080.540.51
Pb Ratio4.164.274.184.041.511.43
Ev To Sales7.197.857.397.153.884.0
Roic0.10.06010.08170.09660.02240.0213
Net Income Per Share1.61.571.041.481.890.9
Days Of Inventory On Hand398.14384.62361.61413.79564.73592.96
Payables Turnover6.167.3111.9510.99.676.42
Research And Ddevelopement To Revenue0.07650.110.10.07140.07910.0616
Cash Per Share3.473.144.334.44.444.58
Pocfratio33.9532.3426.3341.8124.7519.58
Pfcf Ratio57.6747.5833.1571.4636.4750.48
Days Payables Outstanding49.9230.5633.549.9637.7352.94
Income Quality1.111.941.850.941.981.05
Ev To Operating Cash Flow32.8231.1625.6441.024.9718.02
Pe Ratio37.6162.8648.7539.2449.0525.09
Ev To Free Cash Flow55.7645.8432.370.0836.827.02
Earnings Yield0.02660.01590.02050.02550.02040.0194
Intangibles To Total Assets0.190.160.140.130.460.49
Net Debt To E B I T D A(0.8)(1.32)(0.75)(0.47)0.170.18
Current Ratio6.566.176.86.184.887.28
Tangible Book Value Per Share12.0512.8114.8215.7814.4915.22
Receivables Turnover4.845.335.784.713.116.09
Graham Number22.3218.8924.027.9829.430.87
Shareholders Equity Per Share14.1415.2817.2918.3835.3537.12

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
42.231
Earnings Share
0.62
Revenue Per Share
18.217
Quarterly Revenue Growth
0.631
Return On Assets
0.0473
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.